Search - tctmd.com

Displaying 541 - 560 of 7684

Sort: Relevancy | Date

Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign

News Daily News

Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign

February 25, 2025

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

February 24, 2025

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

Women's Heart Health Series: Underrepresentation of Women in Cardiology – Is There a Solution?

Podcast Heart Valve Matters

Women's Heart Health Series: Underrepresentation of Women in Cardiology – Is There a Solution?

February 20, 2025

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

February 19, 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

February 18, 2025

Hypertensive Disorders in Pregnancy Tied to Future Atrial Fibrillation

News Daily News

Hypertensive Disorders in Pregnancy Tied to Future Atrial Fibrillation

February 18, 2025

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

February 14, 2025

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

AHA Scientific Statement Takes Aim at PAD Pain

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

February 13, 2025

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

News Conference News THT 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

February 13, 2025

Acoramidis Approved in Europe for ATTR Cardiomyopathy

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Presentation THT 2025

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Presenter: Jonathan Weinsaft

February 12, 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presentation THT 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 12, 2025

A Patient With HF and AR: How and When to Treat With TAVR and SAVR

Presentation THT 2025

A Patient With HF and AR: How and When to Treat With TAVR and SAVR

Presenter: Torsten Vahl

February 12, 2025

Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure

Presentation THT 2025

Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure

Presenter: Nicolas Van Mieghem

February 12, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.